Try our beta test site
311 studies found for:    GVHD AND acute
Show Display Options
Rank Status Study
1 Unknown  PETCT for Diagnosing and Monitoring Acute GVHD
Condition: Acute Graft Versus Host Disease
Intervention: Other: PETCT
2 Active, not recruiting Study of INCB039110 in Combination With Corticosteroids for the Treatment of Acute GVHD
Condition: Acute Graft Versus Host Disease
Interventions: Drug: INCB039110 (200 mg);   Drug: INCB039110 (300 mg);   Drug: prednisone or methylprednisolone (corticosteroids)
3 Terminated Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD
Condition: Acute Graft Versus Host Disease
Intervention: Drug: Recombinant Human Keratinocyte Growth Factor
4 Completed Exploratory Safety Study of ALD518 in Subjects With Steroid-refractory Acute Graft Versus Host Disease (GVHD)
Condition: Acute GvHD
Intervention: Biological: ALD518
5 Recruiting Safety Follow-up of Treatment With Remestemcel-L in Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD
Condition: Grades B-D Acute Graft Versus Host Disease
Intervention:
6 Recruiting Prophylaxis Roles of IL-2 Treatment on Acute GVHD After Transplantation
Condition: Acute Graft-versus-host Disease
Intervention: Drug: Interleukin-2
7 Terminated Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)
Condition: Glucocorticosteroid Refractory Acute GVHD
Intervention: Drug: Toclizumab
8 Recruiting Mesenchymal Stromal Cells for Acute Graft Versus Host Disease
Condition: Acute GVH Disease
Intervention: Biological: Mesenchymal stromal cell therapy
9 Terminated Intra Arterial (IA) Steroids Infusion for Hepatic Acute Hepatic Graft Versus Host Disease (aGVHD)
Condition: Acute Graft Versus Host Disease
Intervention: Drug: Methylprednisolone (Intra-arterial continuous infusion of corticosteroids)
10 Completed
Has Results
The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease
Condition: Acute Graft Versus Host Disease
Intervention: Drug: Etanercept (Enbrel)
11 Unknown  Mesenchymal Stem Cells for Treatment of Refractory Acute Graft-versus-host Disease
Condition: Acute Graft-versus-host Disease
Interventions: Biological: Mesenchymal stem cells;   Biological: Non-mesenchymal stem cells
12 Terminated Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease
Condition: Acute Graft Versus Host Disease
Intervention: Drug: Tocilizumab
13 Withdrawn Anti-CD3 & Anti-CD7 Ricin A Immunotoxin-Combination for Acute Graft Versus Host Disease
Condition: Acute Graft Versus Host Disease
Intervention: Biological: IT-Combination
14 Recruiting Biomarkers for Acute Graft-versus-host Disease
Condition: Acute GVH Disease
Intervention: Other: no intervention
15 Completed Pharmacological Predictors of Successful Cyclosporine Acute GVHD Prophylaxis in Children Undergoing HSCT
Condition: PHARMACOLOGICAL PREDICTORS OF SUCCESSFUL CYCLOSPORINE ACUTE GRAFT VERSUS HOST DISEASE PROPHYLAXIS IN CHILDREN UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANT
Intervention:
16 Recruiting Ectoin Dermatitis Cream 7% as First-line Therapy of Acute Skin Graft Versus Host Disease
Condition: Acute Graft Versus Host Disease in Skin
Intervention:
17 Recruiting MicroRNAs as Diagnostic and Predictive Biomarkers for Acute Graft Versus Host Disease
Condition: Acute GVH Disease
Intervention: Other: Peripheral Venipuncture or Blood draw from Central Line
18 Enrolling by invitation Safety and Efficacy of UC-MSC in Patients With Acute Severe Graft-versus-host Disease
Condition: Acute GVH Disease
Intervention: Biological: Human Umbilical Cord Derived MSC
19 Recruiting Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease
Condition: Acute Graft Versus Host Disease
Interventions: Drug: natalizumab;   Drug: steroids
20 Not yet recruiting Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease
Condition: Acute-graft-versus-host Disease
Interventions: Drug: Cannabidiol;   Drug: Methylprednisolone;   Drug: Calcineurin inhibitor

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.